Velico and South Texas Blood and Tissue Center Partner for Innovation
In a remarkable development within the medical community, Velico, Inc. has established a key partnership with the South Texas Blood and Tissue Center (STBT). This collaboration marks a significant milestone as STBT becomes the first U.S. civilian blood center to implement Velico's advanced FrontlineODP™ system, designed to innovate the spray drying of human plasma. Through this partnership, both organizations aim to set new standards in the field of prehospital transfusion.
About the FrontlineODP™ System
The FrontlineODP™ system is a pioneering technology that produces on-demand spray dried plasma, a vital resource for transfusions, especially in critical situations where traditional plasma products are either unavailable or difficult to handle. This groundbreaking system utilizes a proprietary spray drying process, which transforms liquid plasma into a stable powdered form that can be stored at room temperature. This innovation allows for rapid reconstitution with sterile water, making it ready for transfusion in just approximately 2 ½ minutes.
Benefits for Emergency and Rural Services
The practical applications of Velico's FrontlineODP™ system are vast, targeting crucial sectors such as:
- Emergency Medical Services: Providing much-needed plasma for first responders, including air and ground ambulances, enhancing their ability to deliver critical care swiftly.
- Rural Healthcare: Offering a solution for rural hospitals lacking access to conventional plasma inventories, ensuring timely care for patients in remote areas.
- Military Operations: Facilitating access to plasma in battlefield conditions, where time and resources are limited.
- Mass Casualty Situations: Enabling rapid deployment of stockpiled plasma during emergencies involving multiple casualties, thus saving lives in urgent circumstances.
Leadership Insights on Collaboration
Richard Meehan, the President and CEO of Velico Medical, expressed his enthusiasm for collaborating with STBT. Meehan noted that this initiative is instrumental in advancing best practices and preparing for the commercial launch of the FrontlineODP™ system. He remarked, "FrontlineODP™ has the potential to be a transformative, life-saving solution for emergency medical providers, capable of saving thousands of lives annually." This partnership not only seeks to improve transfusion practices but also to enhance operational readiness for those in the field.
Similarly, Audra Taylor, Executive Director of Blood Operations at STBT, emphasized the significance of the BCEP initiative. Taylor highlighted the program's potential to revolutionize the way emergency medical services operate, particularly in scenarios where traditional blood products are unavailable due to logistical obstacles. With FrontlineODP™, many EMS and emergency providers can now tap into life-saving plasma resources that were once beyond their reach.
Regulatory Status and Development Support
It is crucial to note that the FrontlineODP™ system remains in the investigational phase and has not yet received FDA approval for its use. As a result, its application is currently limited to investigational use only. Nonetheless, Velico’s commitment, bolstered by federal funding from the Department of Health and Human Services, underscores the project's importance and potential impact on healthcare systems nationwide.
About Velico, Inc.
Velico, Inc., headquartered in Beverly, Massachusetts, is a private medical technology company dedicated to addressing preventable death caused by bleeding. With extensive experience in transfusion medicine, Velico is focused on developing collaborations with leaders in civilian and military blood centers, as well as engaging with trauma surgeons and emergency medical personnel worldwide. Their mission aligns with ensuring accessibility to life-saving therapies whenever they are needed most.
About South Texas Blood and Tissue Center
As a prominent blood service provider, South Texas Blood and Tissue Center supplies blood components to over 100 hospitals throughout its region. In addition to blood services, STBT plays a crucial role in tissue donation and supports research initiatives aimed at advancing new therapies. The organization has a rich history of collaborating with healthcare providers to deliver life-saving treatments and keep pace with the evolving landscape of medical practices.
Frequently Asked Questions
What is the function of Velico's FrontlineODP™ system?
The FrontlineODP™ system produces on-demand spray dried plasma for quick and efficient transfusions in emergency situations.
How does the FrontlineODP™ system improve emergency care?
This system allows first responders to access life-saving plasma more efficiently, especially in environments with limited resources.
Is the FrontlineODP™ system FDA approved?
No, the system is currently in the investigational phase and has not yet received FDA approval.
What is the significance of the partnership between Velico and STBT?
This partnership sets a precedent for innovative blood transfusion techniques and enhances the capabilities of emergency medical services.
Who can benefit from the FrontlineODP™ technology?
First responders, rural hospitals, military applications, and services responding to mass casualty events stand to benefit significantly from this technology.
